Intraaortic Balloon Pump
FDA designates recall of two intra-aortic balloon pumps as class I
The FDA announces a recall of intra-aortic balloon pumps manufactured by Datascope/Maquet/Getinge due to risk for unexpected shutdown due to electrical failure in the power management or solenoid boards.
Safety of percutaneous microaxial LVAD for cardiogenic shock uncertain vs. other options
For patients presenting with acute MI with cardiogenic shock, the safety of percutaneous microaxial left ventricular assist device use vs. other treatments could not be well established using observational Medicare data, findings show.
FDA designates intra-aortic balloon pump recall as class I
The FDA announced it has designated a recall of intra-aortic balloon pumps by Datascope/Getinge as class I, the most serious kind.
Intra-aortic balloon pump recall designated class I by FDA
Datascope/Getinge announced a recall of its intra-aortic balloon pumps due to risk for blood entering the pump through a damaged balloon catheter — also called a blood back event — and causing harm to the patient.
FDA designates intra-aortic balloon pump recall as class I
Arrow International announced it is recalling its intra-aortic balloon pumps after receiving complaints about shorter than expected battery power.
Intra-aortic balloon pumps recalled due to fluid leak issue
The FDA announced it designated a recall of intra-aortic balloon pumps due to problems related to fluid leak as class 1, the most serious type.
FDA designates recall of two intra-aortic balloon pumps as class 1
The FDA has designated Arrow International’s recall of two intra-aortic balloon pumps as a class 1 recall, the most serious kind.